Citadel Advisors’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-25,890
| Closed | -$470K | – | 5919 |
|
|
2020
Q3 | $470K | Sell |
25,890
-126,311
| -83% | -$2.29M | ﹤0.01% | 3548 |
|
|
2020
Q2 | $2.09M | Buy |
152,201
+49,509
| +48% | +$678K | ﹤0.01% | 2213 |
|
|
2020
Q1 | $1.47M | Sell |
102,692
-186,972
| -65% | -$2.67M | ﹤0.01% | 2511 |
|
|
2019
Q4 | $4.91M | Buy |
289,664
+262,312
| +959% | +$4.44M | ﹤0.01% | 1654 |
|
|
2019
Q3 | $421K | Sell |
27,352
-601,342
| -96% | -$9.26M | ﹤0.01% | 3600 |
|
|
2019
Q2 | $14.7M | Sell |
628,694
-495
| -0.1% | -$11.6K | 0.01% | 954 |
|
|
2019
Q1 | $17.8M | Buy |
629,189
+423,922
| +207% | +$12M | 0.01% | 797 |
|
|
2018
Q4 | $6.19M | Buy |
205,267
+116,623
| +132% | +$3.52M | ﹤0.01% | 1301 |
|
|
2018
Q3 | $3.1M | Buy |
88,644
+79,661
| +887% | +$2.79M | ﹤0.01% | 1874 |
|
|
2018
Q2 | $213K | Buy |
+8,983
| New | +$213K | ﹤0.01% | 3651 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4590 |
|